Interventional Radiology Products Market worth $14.1 billion by 2026 – Rising prevalence of chronic diseases

(I-BusinessNews.Com, August 05, 2021 ) The global interventional radiology products market is projected to USD 14.1 billion by 2026 from USD 10.2 billion in 2021, at a CAGR of 6.6% during the forecast period Rising prevalence of chronic diseases, growing geriatric population, increasing demand for minimally invasive procedures and favorable reimbursement scenario for interventional radiology procedures are the major factors driving the growth of the interventional radiology products market.

Browse 132 market data Tables and 39 Figures spread through 219 Pages and in-depth TOC on “Interventional Radiology Products Market”

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=67681703

North America was the largest regional market for interventional radiology products market in 2020.

The interventional radiology products is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2020, North America was the largest regional segment of the overall market, followed by Europe. The large share of the North American market can be attributed to the high prevalence of chronic diseases, growing geriatric population, increasing adoption of minimally invasive procedures, and the presence of key players in the region.
Key Market Players

The prominent players operating in this market include Abbott (US), Medtronic (Ireland), Boston Scientific Corporation (US), Becton Dickinson and Company (US), Terumo Medical Corporation (Japan), and Cardinal Health (US)

MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com

Source: EmailWire.Com